Key facts
- It has raised $50K; the latest was Early Stage VC in Aug 2025.
- Notable investors include Cambridge Enterprise Ventures, Founders at the University of Cambridge, ICURe, Pioneer Group.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Electra Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Electra Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Electra Bio
Developer of an organ-on-chip technology designed to improve drug discovery and research capabilities. The company integrates biology with electronics to create bioelectronic lab-grown organs, enabling the healthcare industry to generate predictive data and accelerate in vitro testing.
- Sector
- Healthcare
- HQ
- Cambridge, United Kingdom
- Founded
- 2024
- Employees
- 4
- Website
- electra.bio/
- Ownership
- Privately Held (backing)
Electra Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Electra Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Electra Bio in its N-PORT filings yet. We sweep new filings monthly.